Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wayne B Batchelor

Showing results (71-80 of 85) with videos related to

Pageof 9
Sort By:
Journal of the American College of Cardiology|April 19, 2008
A novel bioresorbable polymer paclitaxel-eluting stent for the treatment of single and multivessel coronary disease: primary results of the COSTAR (Cobalt Chromium Stent With Antiproliferative for Restenosis) II studyMitchell W Krucoff, Dean J Kereiakes, John L Petersen, et al.
JAMA Cardiology|December 8, 2022
Characteristics of Clinical Trial Sites for Novel Transcatheter Mitral and Tricuspid Valvular TherapiesAshwin S Nathan, Kriyana P Reddy, Lin Yang, et al.
International Journal of Cardiology|September 13, 2024
Clinical outcomes among patients with mitral valve regurgitation undergoing Impella-supported high-risk PCIArsalan Abu-Much, Cindy L Grines, Shmuel Chen, et al.
JACC. Advances|October 30, 2025
Percutaneous Coronary Intervention or Medical Therapy for Chronic Total Occlusion in Older AdultsYasser Jamil, Matthew Dermksian, Alaaeddine El Ghazawi, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|August 12, 2024
Breaking Down Barriers to Transcatheter Aortic Valve ReplacementAmit N Vora, Wayne B Batchelor, Konstantinos Dean Boudoulas, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|November 21, 2025
Short-Term Outcomes of Impella-Supported High-Risk Percutaneous Coronary Intervention in Surgically Ineligible Patients: Insights From PROTECT IIIBatla Falah, Behnam N Tehrani, Julia B Thompson, et al.
Frontiers in Cardiovascular Medicine|March 28, 2024
Contemporary approach to cardiogenic shock care: a state-of-the-art reviewAditya Mehta, Ilan Vavilin, Andrew H Nguyen, et al.
JACC. Advances|June 28, 2024
The Multidisciplinary Heart Team in Cardiovascular Medicine: Current Role and Future ChallengesWayne B Batchelor, Saif Anwaruddin, Dee Dee Wang, et al.
ESC Heart Failure|November 5, 2025
Impact of standardized team-based care on cardiogenic shock outcomes over timeBehnam N Tehrani, Carolyn M Rosner, Adetokunbo Fadahunsi, et al.
ESC Heart Failure|September 27, 2024
Guideline-directed medical therapy implementation during hospitalization for cardiogenic shockMatthew G Dimond, Carolyn M Rosner, Seiyon Ben Lee, et al.
Pageof 9

Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
Journal of the American College of Cardiology|April 19, 2008
A novel bioresorbable polymer paclitaxel-eluting stent for the treatment of single and multivessel coronary disease: primary results of the COSTAR (Cobalt Chromium Stent With Antiproliferative for Restenosis) II studyMitchell W Krucoff, Dean J Kereiakes, John L Petersen, et al.
JAMA Cardiology|December 8, 2022
Characteristics of Clinical Trial Sites for Novel Transcatheter Mitral and Tricuspid Valvular TherapiesAshwin S Nathan, Kriyana P Reddy, Lin Yang, et al.
International Journal of Cardiology|September 13, 2024
Clinical outcomes among patients with mitral valve regurgitation undergoing Impella-supported high-risk PCIArsalan Abu-Much, Cindy L Grines, Shmuel Chen, et al.
JACC. Advances|October 30, 2025
Percutaneous Coronary Intervention or Medical Therapy for Chronic Total Occlusion in Older AdultsYasser Jamil, Matthew Dermksian, Alaaeddine El Ghazawi, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|August 12, 2024
Breaking Down Barriers to Transcatheter Aortic Valve ReplacementAmit N Vora, Wayne B Batchelor, Konstantinos Dean Boudoulas, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|November 21, 2025
Short-Term Outcomes of Impella-Supported High-Risk Percutaneous Coronary Intervention in Surgically Ineligible Patients: Insights From PROTECT IIIBatla Falah, Behnam N Tehrani, Julia B Thompson, et al.
Frontiers in Cardiovascular Medicine|March 28, 2024
Contemporary approach to cardiogenic shock care: a state-of-the-art reviewAditya Mehta, Ilan Vavilin, Andrew H Nguyen, et al.
JACC. Advances|June 28, 2024
The Multidisciplinary Heart Team in Cardiovascular Medicine: Current Role and Future ChallengesWayne B Batchelor, Saif Anwaruddin, Dee Dee Wang, et al.
ESC Heart Failure|November 5, 2025
Impact of standardized team-based care on cardiogenic shock outcomes over timeBehnam N Tehrani, Carolyn M Rosner, Adetokunbo Fadahunsi, et al.
ESC Heart Failure|September 27, 2024
Guideline-directed medical therapy implementation during hospitalization for cardiogenic shockMatthew G Dimond, Carolyn M Rosner, Seiyon Ben Lee, et al.
Pageof 9